Dimensional Fund Advisors LP Gain Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$2.07 - $3.4 $1,931 - $3,172	-933 Reduced 5.55%	15,886 $51,000
Q3 2023 Nov 09, 2023	SELL	$3.19 - $4.68 $13,216 - $19,389	-4,143 Reduced 19.76%	16,819 $55,000
Q2 2023 Aug 09, 2023	BUY	$4.36 - $5.5 $10,267 - $12,952	2,355 Added 12.66%	20,962 $93,000
Q1 2023 May 12, 2023	BUY	$3.18 - $5.16 $21,181 - $34,370	6,661 Added 55.76%	18,607 $89,000
Q4 2022 Feb 09, 2023	BUY	$2.89 - $3.35 $11 - $13	4 Added 0.03%	11,946 $37,000
Q3 2022 Nov 10, 2022	BUY	$3.17 - $4.21 $37,856 - $50,275	11,942 New	11,942 $39,000

2.39M

10K

Ticker GANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,883,400
Market Cap $19M
Description
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.